Howard Wolinsky takes another step on his active surveillance travels

Posted on September 6, 2016 by Sitemaster

In his latest post on the MedPage Today web site, Howard Wolinsky (a freelance journalist based in the Chicago area), who has been on active surveillance since 2010, writes about the result of his most recent rebiopsy. His last one was in 2013. There was (again) “no evidence of malignancy” in the post-biopsy pathology report. … READ MORE …

Filed under: Living with Prostate Cancer, Management | Tagged: , , , | 3 Comments »

The clinical significance of high-grade PIN — an update

Posted on December 23, 2011 by Sitemaster

A newly published mini-review in BJU International deals with the biologic and clinical significance of high-grade prostatic intraepithelial neoplasia (HG-PIN) as a sole finon an initial biopsy for risk of prostate cancer. … READ MORE …

Filed under: Diagnosis, Management, Risk | Tagged: , , , | Leave a comment »

The Tuesday news update: March 3, 2009

Posted on March 3, 2009 by Sitemaster

Today’s news covers:

  • The ongoing trial of toremifene 20 mg in prevention of prostate cancer
  • Interleukin-6 in the development of prostate cancer
  • Preservation of the fascia and recovery of erectile function post-surgery
  • The use of urethral wall stents and delayed artificial urinary sphincters to treat men with severe, recurrent bladder neck contracture and incontinence after radical prostatectomy … READ MORE …

Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: , , , , , , , , , , | 1 Comment »

Prostate cancer news update, PART A: Tuesday, July 28

Posted on July 29, 2008 by Sitemaster

There’s a lot of news this morning, so we are breaking it up into two sections (Parts A and B) to make it easier to read. … MORE …

Filed under: Diagnosis, Drugs in development, Management, Prevention, Treatment | Tagged: , , , , , , , , , , , | 1 Comment »